 |
|
A Structured Literature Review of Treatment for Localized Prostate Cancer
John H. Wasson, MD;
Cynthia C. Cushman, MD;
Reginald C. Bruskewitz, MD;
Benjamin Littenberg, MD;
Albert G. Mulley, Jr, MD, MPP;
John E. Wennberg, MD, MPH
Arch Fam Med. 1993;2(5):487-493.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Montie JE, Wood DP, Pontes JE, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer. 1989;63:381-385.
PUBMED
2. Mameghan H, Fisher R, Watt WH, et al. Results of radiotherapy for localised prostatic carcinoma treated at the Prince of Wales Hospital, Sydney. Med J Aust. 1991;154:317-324.
PUBMED
3. Cantrell BB, DeKlerk DP, Eggleston JC, Boitnott JK, Walsh PC. Pathological factors that influence prognosis in stage A prostatic cancer: the influence of extent vs grade. J Urol. 1980;125:516-520.
4. Lowe BA, Listrom MB. Incidental carcinoma of the prostate: an analysis of the predictors of progression. J Urol. 1988;140:1340-1344.
PUBMED
5. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer. 1990;66:1225-1233.
PUBMED
6. Graversen PH, Nielsen KT, Gasser TC, Corle DK, Madsen PO. Radical prostatectomy vs expectant primary treatment in stages I and II prostatic cancer: a 15-year follow-up. Urology. 1990;36:493-498.
PUBMED
7. Paulson D, Lin G, Hinshaw W, Stephani S. Radical surgery vs radiotherapy for adenocarcinoma of the prostate. J Urol. 1982;128:502-504.
PUBMED
8. El-Mahdi A, Kuban D, Schellhammer P. The treatment of choice for localized poorly differentiated adenocarcinoma of the prostate. Am J Clin Oncol. 1985;8:477-480.
PUBMED
9. Kuban D, El-Mahdi A, Schellhammer P. I-125 interstitial implantation for prostate cancer. Cancer. 1989;63:2415-2420.
PUBMED
10. Olsson C, Babayan R, White R. Surgical management of stage B or C prostatic carcinoma: radical surgery vs radiotherapy. Urology. 1985;25(suppl):30-38.
PUBMED
11. Morton J, Harrison L, Peschel R. Prostatic cancer therapy: comparison of externalbeam radiation and 1-125 seed implantation treatment of stages B and C neoplasms. Radiology. 1986;159:249-252.
FREE FULL TEXT
12. Fowler J, Barzell W, Hilaris B, Whitmore W. Complication of 125iodine implantation and pelvic lymphadenectomy in the treatment of prostatic cancer. J Urol. 1979;121:447-451.
PUBMED
13. Snedecor GW, Cochran WG. Statistical Methods. 7th ed. Ames: Iowa State University Press; 1980:136-137. 14. Fowler J. Radical prostatectomy for stage A2 and B prostatic carcinoma. Urology. 1985;26:1-3.
PUBMED
15. Paulson D, Walther P. Is grade or stage of primary importance in determining the outcome after radical prostatectomy for disease clinically confined to the prostate? Br J Urol. 1989;62:310-315.
16. Paulson D, Robertson J, Daubert L, Walther P. Radical prostatectomy in stage A prostatic adenocarcinoma. J Urol. 1988;140:535-538.
PUBMED
17. Morton R, Steiner M, Walsh P. Cancer control following anatomical radical prostatectomy: an interim report. J Urol. 1991;145:1197-200.
PUBMED
18. Catalona WJ, Bigg SW. Nerve-sparing radical prostatectomy: evaluation of results after 250 patients. J Urol. 1990;143:538-543.
PUBMED
19. Quinlan DM, Epstein JI, Carter BS, Walsh PC. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol. 1991;115:998-1002.
20. Black WC, Ling A. Is earlier diagnosis really better? the misleading effects of lead time and length biases. AJR Am J Roentgenol. 1990;155:625-630.
FREE FULL TEXT
21. Wishnow KI, Tenney DM. Will Rogers and the results of radical cystectomy for invasive bladder cancer. Urol Clin North Am. 1991;18:529-537.
PUBMED
22. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;12:1604-1608.
23. Walsh PC, Jewett HJ. Radical surgery for prostatic cancer. Cancer. 1980;45:1906-1911.
PUBMED
24. Bagshaw M. Radiotherapy of Stage B2 Lesions of the Prostate. New York, NY: Alan R Liss Inc; 1987:379-396. 25. Ries LAG, Hankey BF, Miller BA, Hartman AM, Edwards BK. Cancer Statistics Review 1973-88. Bethesda, Md: National Cancer Institute; 1991. Publication No. 91-2789. 26. Lee F, Littrup PJ, Loft-Christensen L, et al. Predicted prostate-specific antigen results using transrectal ultrasound gland volume: differentiation of benign prostatic hyperplasia and prostate cancer. Cancer. 1992;70(suppl):211-220.
PUBMED
27. Johansson JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L, Krusemo UB. High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA. 1992;267:2191-2196.
FREE FULL TEXT
28. Hinman F Jr. Screening for prostatic carcinoma. J Urol. 1991;145:126-130.
PUBMED
29. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE, for the Prostate Patient Outcomes Research Team. An assessment of radical prostatectomy: time trends, geographic variation, and outcomes. JAMA. In press. 30. Hanks GE. Radiotherapy or surgery for prostate cancer? 10- and 15-year results of external beam therapy. Acta Oncol. 1991;30:231-237.
PUBMED
31. Gallee MPW, Ten Kate FJW, Mulder PGH, Blom JHM, Van Der Heul RO. Histological grading of prostatic carcinoma in prostatectomy specimens. Br J Urol. 1990;65:368-375.
PUBMED
32. Mostofi FK, Davis CJ, Sesterhenn IA. Pathology of carcinoma of the prostate. Cancer. 1992;70(suppl):235-253.
PUBMED
|
